JAK-话题@MedSci

#JAK#

115篇内容 | 1147人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738077, encodeId=03411e3807752, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤, objectType=article, longId=728080, objectId=069ce2808010, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=069ce2808010, replyNumber=0, likeNumber=39, createdTime=2022-12-29, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=069ce2808010, moduleTitle=Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=069ce2808010)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738076, encodeId=497f1e3807632, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=J Dermatolog Treat：JAK抑制剂联合紫外光疗可更有效的治疗白癜风, objectType=article, longId=724908, objectId=0f35e24908bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f35e24908bc, replyNumber=0, likeNumber=47, createdTime=2023-04-04, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f35e24908bc, moduleTitle=J Dermatolog Treat：JAK抑制剂联合紫外光疗可更有效的治疗白癜风, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f35e24908bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738069, encodeId=ff001e38069bf, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK抑制剂「乌帕替尼」在华获批，用于治疗成人和12岁及以上儿童及青少年的难治性、中度至重度特应性皮炎, objectType=article, longId=299190, objectId=b29229919036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b29229919036, replyNumber=0, likeNumber=50, createdTime=2023-02-01, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b29229919036, moduleTitle=JAK抑制剂「乌帕替尼」在华获批，用于治疗成人和12岁及以上儿童及青少年的难治性、中度至重度特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b29229919036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738067, encodeId=31671e38067c3, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle= Blood：采用JAK/STAT抑制剂鲁索替尼治疗T细胞淋巴瘤, objectType=article, longId=295178, objectId=3c1e2951e899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1e2951e899, replyNumber=0, likeNumber=54, createdTime=2022-12-29, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1e2951e899, moduleTitle= Blood：采用JAK/STAT抑制剂鲁索替尼治疗T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1e2951e899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738065, encodeId=10901e38065e1, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变, objectType=article, longId=293708, objectId=a9bd293e08d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9bd293e08d8, replyNumber=0, likeNumber=42, createdTime=2022-11-07, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9bd293e08d8, moduleTitle=免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9bd293e08d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738073, encodeId=379e1e3807335, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAAD：新型氘化JAK抑制剂CTP-543治疗中重度斑秃的效果, objectType=article, longId=723835, objectId=b733e2383591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b733e2383591, replyNumber=0, likeNumber=47, createdTime=2023-03-05, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b733e2383591, moduleTitle=JAAD：新型氘化JAK抑制剂CTP-543治疗中重度斑秃的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b733e2383591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738075, encodeId=50e21e3807573, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=J Clin Rheumatol：类风湿性关节炎使用不同JAK抑制剂发生严重感染的风险并无显著差异, objectType=article, longId=724921, objectId=d518e24921e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d518e24921e1, replyNumber=0, likeNumber=41, createdTime=2022-08-23, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d518e24921e1, moduleTitle=J Clin Rheumatol：类风湿性关节炎使用不同JAK抑制剂发生严重感染的风险并无显著差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d518e24921e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738078, encodeId=27ae1e3807855, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=ARD：超3万数据研究：TNF抑制剂、阿巴西普、IL6抑制剂和JAK抑制剂类风湿性关节炎患者中的有效性, objectType=article, longId=737269, objectId=eb97e3726901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb97e3726901, replyNumber=0, likeNumber=42, createdTime=2023-05-20, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb97e3726901, moduleTitle=ARD：超3万数据研究：TNF抑制剂、阿巴西普、IL6抑制剂和JAK抑制剂类风湿性关节炎患者中的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb97e3726901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738066, encodeId=044c1e3806633, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=AJH：PD-L1 过表达与 JAK2-V617F 突变负担相关，并与骨髓增殖性肿瘤中的 9p 单亲二体性相关。, objectType=article, longId=293934, objectId=e987293934a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e987293934a7, replyNumber=0, likeNumber=36, createdTime=2022-06-03, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e987293934a7, moduleTitle=AJH：PD-L1 过表达与 JAK2-V617F 突变负担相关，并与骨髓增殖性肿瘤中的 9p 单亲二体性相关。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e987293934a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738061, encodeId=04a81e38061ad, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Dermatology：JAK抑制剂是治疗特应性皮炎的一种安全且有效的疗法, objectType=article, longId=219701, objectId=4bfc219e0103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bfc219e0103, replyNumber=0, likeNumber=36, createdTime=2022-02-17, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bfc219e0103, moduleTitle=Dermatology：JAK抑制剂是治疗特应性皮炎的一种安全且有效的疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bfc219e0103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738058, encodeId=18611e38058b4, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！, objectType=article, longId=218077, objectId=95b82180e746, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b82180e746, replyNumber=0, likeNumber=40, createdTime=2021-12-01, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b82180e746, moduleTitle=脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95b82180e746)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738064, encodeId=aa5a1e3806440, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Blood：T细胞淋巴瘤患者采用鲁索替尼靶向抑制JAK/STAT的临床获益情况, objectType=article, longId=293570, objectId=cf392935e0e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf392935e0e0, replyNumber=0, likeNumber=42, createdTime=2022-11-10, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf392935e0e0, moduleTitle=Blood：T细胞淋巴瘤患者采用鲁索替尼靶向抑制JAK/STAT的临床获益情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf392935e0e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738070, encodeId=25871e38070aa, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAAD：JAK抑制剂治疗特应性皮炎的临床试验中老年人的代表性不足, objectType=article, longId=300570, objectId=546b3005e0ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546b3005e0ef, replyNumber=0, likeNumber=59, createdTime=2022-05-04, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546b3005e0ef, moduleTitle=JAAD：JAK抑制剂治疗特应性皮炎的临床试验中老年人的代表性不足, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546b3005e0ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738062, encodeId=73a11e3806254, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK 抑制剂 Olumiant 在 RA 中的新长期阳性数据, objectType=article, longId=220347, objectId=48aa22034ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48aa22034ed7, replyNumber=0, likeNumber=42, createdTime=2022-01-26, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48aa22034ed7, moduleTitle=JAK 抑制剂 Olumiant 在 RA 中的新长期阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48aa22034ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738074, encodeId=97591e38074b5, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=J Clin Rheumatol：类风湿性关节炎患者使用JAK抑制剂感染风险是否会增加？, objectType=article, longId=724209, objectId=2b6fe24209ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b6fe24209ff, replyNumber=0, likeNumber=40, createdTime=2022-12-24, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b6fe24209ff, moduleTitle=J Clin Rheumatol：类风湿性关节炎患者使用JAK抑制剂感染风险是否会增加？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b6fe24209ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738056, encodeId=717e1e38056a6, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Lancet：JAK1抑制剂Filgotinib治疗中重度溃疡性结肠炎, objectType=article, longId=212293, objectId=607e2122932e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=607e2122932e, replyNumber=0, likeNumber=33, createdTime=2022-01-24, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=607e2122932e, moduleTitle=Lancet：JAK1抑制剂Filgotinib治疗中重度溃疡性结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=607e2122932e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738072, encodeId=529b1e3807245, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=ARD：巴瑞替尼（JAK抑制剂）治疗活动性干燥综合征的初步研究, objectType=article, longId=723469, objectId=e50ae23469ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e50ae23469ec, replyNumber=0, likeNumber=43, createdTime=2022-09-14, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e50ae23469ec, moduleTitle=ARD：巴瑞替尼（JAK抑制剂）治疗活动性干燥综合征的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e50ae23469ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738071, encodeId=320e1e38071e4, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, objectType=article, longId=301104, objectId=bf1030110428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1030110428, replyNumber=0, likeNumber=39, createdTime=2023-03-01, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1030110428, moduleTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1030110428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738063, encodeId=28f71e38063c0, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果, objectType=article, longId=292080, objectId=dec9292080e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec9292080e9, replyNumber=0, likeNumber=36, createdTime=2022-02-23, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec9292080e9, moduleTitle=Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec9292080e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738059, encodeId=16e81e3805942, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, objectTitle=JAK抑制剂联合疗法FMX114治疗轻中度特应性皮炎，临床试验中招募了第一位患者, objectType=article, longId=218973, objectId=dbd52189e3d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd52189e3d5, replyNumber=0, likeNumber=30, createdTime=2022-05-08, rootId=0, userName=肉我只吃一口, userId=6e8634348903, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd52189e3d5, moduleTitle=JAK抑制剂联合疗法FMX114治疗轻中度特应性皮炎，临床试验中招募了第一位患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd52189e3d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JAK

2020-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Front Pharmacol:舒泻一号汤通过IL-6/JAK2/STAT3信号通路减轻慢性轻度不可预见性应激诱导的肝损伤

2022-12-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

J Dermatolog Treat：JAK抑制剂联合紫外光疗可更有效的治疗白癜风

2023-04-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK抑制剂「乌帕替尼」在华获批，用于治疗成人和12岁及以上儿童及青少年的难治性、中度至重度特应性皮炎

2023-02-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：采用JAK/STAT抑制剂鲁索替尼治疗T细胞淋巴瘤

2022-12-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变

2022-11-07

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAAD：新型氘化JAK抑制剂CTP-543治疗中重度斑秃的效果

2023-03-05

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

J Clin Rheumatol：类风湿性关节炎使用不同JAK抑制剂发生严重感染的风险并无显著差异

2022-08-23

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

ARD：超3万数据研究：TNF抑制剂、阿巴西普、IL6抑制剂和JAK抑制剂类风湿性关节炎患者中的有效性

2023-05-20

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

AJH：PD-L1 过表达与 JAK2-V617F 突变负担相关，并与骨髓增殖性肿瘤中的 9p 单亲二体性相关。

2022-06-03

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Dermatology：JAK抑制剂是治疗特应性皮炎的一种安全且有效的疗法

2022-02-17

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！

2021-12-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Blood：T细胞淋巴瘤患者采用鲁索替尼靶向抑制JAK/STAT的临床获益情况

2022-11-10

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAAD：JAK抑制剂治疗特应性皮炎的临床试验中老年人的代表性不足

2022-05-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK 抑制剂 Olumiant 在 RA 中的新长期阳性数据

2022-01-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

J Clin Rheumatol：类风湿性关节炎患者使用JAK抑制剂感染风险是否会增加？

2022-12-24

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Lancet：JAK1抑制剂Filgotinib治疗中重度溃疡性结肠炎

2022-01-24

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

ARD：巴瑞替尼（JAK抑制剂）治疗活动性干燥综合征的初步研究

2022-09-14

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒

2023-03-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

Leukemia： JAK2 和 ERK 的双重靶向干扰骨髓增殖性肿瘤克隆并提高治疗效果

2022-02-23

肉我只吃一口 (审核中...)

前往app查看评论内容

#JAK#

JAK抑制剂联合疗法FMX114治疗轻中度特应性皮炎，临床试验中招募了第一位患者

2022-05-08

科室
- - 订阅+
  - 更多科室
工具
服务